Canada Life’s Athenex, Inc. Common Stock ATNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-240
Closed -$15K 2557
2021
Q3
$15K Hold
240
﹤0.01% 2481
2021
Q2
$22K Hold
240
﹤0.01% 2469
2021
Q1
$20K Buy
240
+117
+95% +$22.4K ﹤0.01% 2511
2020
Q4
$27K Hold
123
﹤0.01% 2492
2020
Q3
$30K Hold
123
﹤0.01% 2333
2020
Q2
$33K Sell
123
-162
-57% -$34.3K ﹤0.01% 2376
2020
Q1
$44K Hold
285
﹤0.01% 2169
2019
Q4
$86K Buy
+285
New +$75.3K ﹤0.01% 2109
2019
Q3
Sell
-211
Closed -$83K 2481
2019
Q2
$83K Sell
211
-2
-0.9% -$554 ﹤0.01% 2281
2019
Q1
$52K Hold
213
﹤0.01% 2249
2018
Q4
$52K Hold
213
﹤0.01% 2360
2018
Q3
$66K Hold
213
﹤0.01% 2322
2018
Q2
$80K Buy
+213
New +$72.9K ﹤0.01% 2268

Other funds holding ATNX

Canada Life's ATNX Position: Q4 2021 in Review

Canada Life sold out of Athenex, Inc. Common Stock (ATNX) in Q4 2021, closing a stake of 240 shares — an estimated $15K sold.

Canada Life first reported a position in ATNX in Q2 2018 and held it in 13 quarters. The position peaked at $86K in Q4 2019. 103 funds tracked by Wall St. Rank hold ATNX as of Q4 2021.

  • Canada Life reported no remaining Athenex, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Canada Life sold 240 Athenex, Inc. Common Stock shares in Q4 2021, an estimated $15K.
  • Canada Life first reported a position in Athenex, Inc. Common Stock in Q2 2018 and held it in 13 quarters.
  • Canada Life's Athenex, Inc. Common Stock position peaked at $86K in Q4 2019.
  • 103 funds tracked by Wall St. Rank held Athenex, Inc. Common Stock as of Q4 2021.

Based on Canada Life's 13F filing for Q4 2021, filed 14 Feb 2022.